Journal of Biopharmaceutical Statistics

Title Publication Date Language Citations
Consistency ensured test strategies for supportive evidence of treatment efficacy in noninferiority clinical trials2017/11/27English
Mixture-based gatekeeping procedures in adaptive clinical trials2017/12/28English
Benefit–Risk Assessment Methods in Medical Product Development, edited by Qi Jiang and Weili He2017/02/03English
Data and Safety Monitoring Committees in Clinical Trials2018/01/02English
Methods for efficacy evaluations of antibacterial treatments in multiple body-site infection trials2016/11/01English
Non-inferiority trials with time-to-event data: clarifying the impact of censoring2023/04/12English
Applying latent profile analysis to identify adolescents and young adults with chronic conditions at risk for poor health-related quality of life2023/05/14English
CONFIDENCE INTERVALS AND p-VALUES FOR WILLIAMS' AND OTHER STEP-DOWN MULTIPLE COMPARISON TESTS AGAINST CONTROL2001/01/01English
WHY ARE PHARMACOKINETIC DATA SUMMARIZED BY ARITHMETIC MEANS?2000/02/15English
MULTIPLE IMPUTATION COMPARED WITH SOME INFORMATIVE DROPOUT PROCEDURES IN THE ESTIMATION AND COMPARISON OF RATES OF CHANGE IN LONGITUDINAL CLINICAL TRIALS WITH DROPOUTS2000/04/24English
LINEAR STRUCTURAL EQUATION MODEL IN ANALYZING QUALITY-OF-LIFE DATA FROM CLINICAL TRIALS1999/01/11English
NONPARAMETRIC ANALYSIS OF COVARIANCE FOR HYPOTHESIS TESTING WITH LOGRANK AND WILCOXON SCORES AND SURVIVAL-RATE ESTIMATION IN A RANDOMIZED CLINICAL TRIAL1999/05/24English
NEW MODELS FOR PHARMACOKINETIC DATA BASED ON A GENERALIZED WEIBULL DISTRIBUTION1999/02/23English
A REMARK ON SMALL-SAMPLE PROPERTIES OF LOGISTIC REGRESSION IN THREE-POINT DESIGNS2000/11/22English
HOW TO ASSESS THE RELATIVE RANGE OF TWO CONSECUTIVE LABORATORY MEASUREMENTS TO MONITOR PATIENTS2001/01/01English
Modelling alternately recurring events using subject specific hazard estimation approach2024/03/03English
A MEASURE OF ASSOCIATION BETWEEN TWO SETS OF MULTIVARIATE RESPONSES2001/01/01English
MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION1999/05/24English
DESIGN AND ANALYSIS OF TRIALS WITH QUALITY OF LIFE AS AN OUTCOME: A PRACTICAL GUIDE2001/01/01English
An enriched approach to combining high-dimensional genomic and low-dimensional phenotypic data2024/04/05English
Covariate adjusted meta-analytic predictive (CA-MAP) prior for historical borrowing using patient-level data2024/04/01English
Regional consistency assessment in multiregional clinical trials2024/04/01English
Adaptively leverage multiple real-world data sources for treatment effect estimation based on similarity2024/04/01English
Estimating treatment effect in randomized trial after control to treatment crossover using external controls2024/04/01English
Empower clinical development by harnessing data from diverse sources: methodology, applications and regulatory perspectives2024/04/01English
Optimization of EWOC principle in BLRM design for phase 1 oncology trials2024/04/01English
genRCT: a statistical analysis framework for generalizing RCT findings to real-world population2024/04/08English
Assessing the use of GEE methods for analyzing binary outcomes in family studies: the Strong Heart Family Study2024/03/29English
FDA experiences with a centralized statistical monitoring tool2024/03/29English
Addressing sequential and concurrent treatment regimens in a small n sequential, multiple assignment, randomized trial (snSMART) in the MISTIC study2023/12/14English